Biosimulation Technology Market
Biosimulation Technology Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biosimulation Technology Market Size and Growth
The biosimulation technology market is witnessing robust growth, driven by increasing demand for drug development and personalized medicine. The market size is projected to reach approximately $4 billion by 2028, with an anticipated CAGR of 14% from 2023. Key factors include advancements in computational modeling and rising healthcare investments.
Companies Covered
(Covid 19 Impact Covered)
◍ Certara USA
◍ Simulation Plus
◍ Dassault Systèmes
◍ Schrodinger
◍ Advanced Chemistry Development
◍ Chemical Computing Group
◍ Entelos
◍ Genedata
◍ Physiomics
◍ Rhenovia Pharma
The biosimulation technology market features companies like Certara USA, Simulation Plus, and Dassault Systèmes, which utilize advanced modeling for drug development, enhancing efficiency and reducing costs. They contribute to market growth through innovative software solutions, collaborations, and expanding applications in pharmaceutical research. Key revenue figures include:
- Certara: $310 million
- Simulation Plus: $32 million
- Dassault Systèmes: €4.5 billion (approx. $5.3 billion) in life sciences segment.
Request Sample Report
Market Segmentation
By Application
Drug development
Drug discovery
Others
Request Sample Report
By Product
Software
Service
Market Growth
Request Sample Report
$ X Billion USD
